eLetters

61 e-Letters

published between 2007 and 2010

  • Not false positive tests- Just different populations
    Guduru Gopal Rao

    Dear Editor

    In their letter Aghaizu et al suggest that the differences in the prevalence in their study 1 and our study 2may be attributable to false positive tests using strand displacement assay (ProbeTec, Becton Dickenson). We disagree with these observations. We would like to point out that the populations studied were substantially different- majority of our subjects attended sexual health and reproduction clinics...

    Show More
  • Missing PID: Is it a reflection of training?
    Ranjana Rani

    Dear Editor,

    This report confirms that PID can be often be missed clinically. Other than lowering the threshold for diagnosis, there could be other ways of improving diagnosis of PID. Training background may have contributed to the different rate of diagnosis among doctors. It would be important to review whether high diagnosing doctors were more likely to have had gynaecology training compared with low diagnosing d...

    Show More
  • Re: Why do people decline HIV testing?
    Helen L Munro

    Dear Editor,

    In response to M O Ramogi on 21st August 2008, it is important to point out that since only patients attending with a new episode were included in the study, those experiencing chronic/recurrent infections or attending solely for treatment were excluded. Therefore the inclusion of patients for who HIV testing is less applicable is unlikely to be the explanation for the association between symptoms of an STI...

    Show More
  • Screening for genital and anorectal sexually transmitted infections in HIV prevention trials in Afri
    Marianne L. Grijsen

    Dear Dr. Potterat and colleagues,

    Thank you for responding to our manuscript. We have carefully reviewed your comments. Below, please find our responses to the questions raised.

    The first comment raised concerns the fact that “sexual factors may have played a lesser role in observed HIV and syphilis prevalence’s than nonsexual factors.” The sexual transmission of sexually transmitted infections including HI...

    Show More
  • Why do people decline HIV testing?
    Manjula Pammi

    Dear Editor,

    Although the uptake of the HIV test has increased significantly in recent years, following the introduction of opt-out screening programmes, there is still a substantial number of the HIV population that is still undiagnosed.1 Therefore, we read with interest the National study of HIV testing in men who have sex with men attending genitourinary clinics in the United Kingdom by H L Munro et el.2 This st...

    Show More
  • HPV Vaccination: Ethical imperatives and clinical indications for Gardasil
    Peter Greenhouse

    Dear Editor,

    In supporting Colm O’Mahony’s editorial (1), I would like to amplify Karen Rogstad’s concern (2) about the unwitting creation of a two-tier healthcare system for HPV vaccination and the social discord which will inevitably result from the Government’s decision.

    Any well-informed parent of sufficient means would want to protect their children against genital warts, so their daughters will necessa...

    Show More
  • STI symptoms and less offer of HIV test , possible explanation
    Malaki O Ramogi

    Dear Editor,

    An interesting finding in this study was the association between having STI symptoms and less chance of being offered HIV test as compared with the patients with no STI symptoms. However the study fails to describe what symptoms these patients might have had. One explanation could be that these patients had chronic recurrent symptoms like genital herpes, chronic non specific urethritis or genital warts an...

    Show More
  • HPV immunization programme
    Peter G Watson

    Dear Editor,

    When Dr O’Mahony gets round to reading my letter properly he will see that I did not express scepticism about deriving benefit from the addition of HPV types 6 and 11 to types 16 and 18 in the immunization programme. I stated that I know of no evidence that the addition would help in preventing carcinoma of the cervix. Dr O’Mahony might believe that the immunization programme is about HPV immunization...

    Show More
  • HPV vaccine programme- Increasing inequality in adolescent's sexual health?
    Karen E Rogstad

    Dear Editor,

    O'Mahony's editorial (1) reflects the concern I and others specialising in STIs in young people have about the decision not to vaccinate girls and young women against genital warts types 6 and 11. Others have commented on the biological, psychosocial and cost issues of external genital warts, and I will not re-iterate these (2,3,4). What has been ignored is that at a time when government is trying to red...

    Show More
  • HPV immunisation decision
    Margaret A Stanley

    Dear Editor,

    I have read the editorial from Dr O’Mahony and the comment from Dr Watson with interest. It may be helpful in this discussion to note that the criteria for selection of an HPV vaccine were spelt out by the Minister Dawn Primarolo on the 2cd of July 2008 in response to a Parliamentary question and is detailed in Hansard http://www.parliament.the-stationery-office.co.uk/pa/cm200708/cmhansrd/cm080702/text/...

    Show More

Pages